Pharyngeal Diseases  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00436800: Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Completed
2
41
RoW
Gemcitabine, Oxaliplatin
Sanofi
Nasopharyngeal Neoplasms
10/08
10/08
NCT00439426: A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.

Completed
2
25
RoW
Oxaliplatin, capecitabine [Xeloda]
Hoffmann-La Roche
Nasopharyngeal Cancer
09/09
09/09

Download Options